Quentir Medicine Monitor
Evidence-based insights for quantum medicine. Published by Quentir Systems LLC · November 1, 2026.
Three researchers working in Egypt, Kuwait, Saudi Arabia and India have designed, on a computer, a layered sensor meant to tell frozen oral cancer tissue from frozen healthy tissue with terahertz radiation. The device is a one-dimensional photonic crystal: thin alternating layers of silicon dioxide and porous silicon stacked on both sides of a central gap that would hold the tissue sample. Its distinctive feature is parity-time symmetry, a design rule taken from quantum mechanics in which layers that amplify light are balanced against layers that absorb it.
The paper, by Zaky A. Zaky of Beni-Suef University and the Gulf University for Science and Technology in Kuwait, Ali Hennache of Imam Mohammad Ibn Saud Islamic University in Riyadh and Abinash Panda of the CMR Institute of Technology in Bengaluru, appeared in the open-access journal Scientific Reports on 31 October 2026. Its headline figure is a transmittance-based sensitivity of 2.4 × 1011 percent per refractive index unit in the band between 0.9 and 1.1 terahertz. Every performance figure for the sensor comes from numerical simulation. No sensor was built for the study, and no new tissue was measured for it.
The authors' clinical target is oral cancer, and they cite more than 400,000 new oral cancer diagnoses a year and note that about 90 percent of oral cancers are squamous cell carcinomas. They list the drawbacks of diagnosis by visual inspection, palpation, vital staining and biopsy: results that vary with the clinician, pain, a risk of bleeding or infection, cost, waiting time and sampling error. The sensor in this paper would still examine excised tissue, so it would not remove the need to take a sample, and any gain in speed, cost or consistency remains untested.
What Zaky, Hennache and Panda designed for Scientific Reports, and where their tissue data come from
The Scientific Reports article describes a stack of silicon dioxide and porous silicon bilayers repeated on each side of a defect layer 40 micrometers thick, all on a substrate. Without the defect, the stack blocks terahertz waves between about 0.58 and 0.72 terahertz. The defect opens a narrow transmission peak inside that blocked band, and the frequency and height of the peak depend on the refractive index of whatever fills the gap. Cancerous and healthy oral tissue bend and absorb terahertz waves differently, so the peak moves when one replaces the other. The authors computed this with the transfer matrix method, a standard calculation of how a wave passes through a stack of layers.
The tissue properties in the model come from a single earlier experiment. The authors fitted polynomial curves to the refractive index and absorption that Yookyeong Carolyn Sim, Joo-Hiuk Son and colleagues reported in Biomedical Optics Express in July 2013. That study imaged seven oral tissues resected from four patients between 0.2 and 1.2 terahertz, at minus 20 °C and at 20 °C, and compared the maps with histology. Freezing gave a larger spectral difference between oral cancer and normal mucosa than room temperature did, which is why the new design targets tissue held at minus 20 °C.
The authors also tuned the porosity of the porous silicon layers between 0 and 35 percent. Higher porosity raised the defect peak toward full transmission, while the peak broadened from about 0.003 to 0.005 terahertz at low porosity to 0.017 terahertz at 35 percent, and the frequency sensitivity fell from 0.028 terahertz per refractive index unit at zero porosity. Above 25 percent the blocked band began to leak and the peak became unstable. The authors chose 25 percent porosity as their balance of spectral resolution, transmission and sensing performance.
Quantum pillar: not applicable. Technology readiness: TRL 2 of 9. The sensor exists only as a computer model built on tissue measurements from four patients published in 2013, so it sits before any laboratory prototype, any test on tissue samples and any clinical study.
How gain and loss layers from Bender and Boettcher's 1998 physics raise the simulated sensitivity
In 1998 Carl Bender and Stefan Boettcher showed, in a paper first posted to arXiv on 29 November 1997, that a family of non-Hermitian quantum Hamiltonians, which are unchanged under combined reflection in space and reversal of time, can have entirely real energy levels as long as that symmetry is not broken. Optics adopted the idea because light in a material with balanced gain and loss follows an equation of the same form. In 2010 Christian Rüter, Detlef Kip, Mordechai Segev, Demetrios Christodoulides and colleagues reported in Nature Physics the first observation of parity-time symmetry in coupled optical waveguides.
In the new design, the gain layers would be silicon dioxide with embedded colloidal quantum dots, excited by an external optical pump, and the loss layers pure silicon dioxide. The model gives each layer a complex refractive index whose imaginary part is set by a gain and loss coefficient called Q. For Q values of 10.695 and 7.85, the paper reports transmittance-based sensitivities of 2.4 × 1011 and 1.7 × 1010 percent per refractive index unit, with a frequency sensitivity of 68.8 gigahertz per refractive index unit for both settings. The authors state that their binary defect design keeps a clear peak for both healthy and cancerous tissue, where earlier ternary and quasi-periodic parity-time designs pushed one of the two peaks to near-zero transmittance.
Clinicians should read these two figures differently. The transmittance figure measures how much the height of the peak changes, in percent, per unit of refractive index, and parity-time balance can magnify peak height to very large values, so the figure becomes very large. The frequency shift of 68.8 gigahertz per unit is the quantity closer to conventional sensor specifications, and it stayed the same at both Q settings. Neither figure is a diagnostic sensitivity in the clinical sense: the paper reports no true-positive rate, no specificity and no comparison against histology on new samples.
Why Quentir assigns the Scientific Reports oral cancer sensor no quantum pillar
The quantum ingredients are the mathematical idea of parity-time symmetry and the quantum dots proposed as a gain medium. The sensor itself works by classical optics: terahertz waves passing through layers of glass and silicon. Quantum dots in a working diagnostic device are a separate matter, as in the electrochemical sensor that Quentir described when a team reported a University of South Africa quantum dot sensor for SARS-CoV-2 spike protein in wastewater. Layered and topological photonic structures also appear in quantum research proper, for example in the 21 laser-written microresonators on one glass fiber built by the Army Research Laboratory and the University of Maryland. The oral cancer design borrows the physics vocabulary of that field without using quantum sensing, computing or simulation hardware.
What a head-and-neck surgeon, pathologist or hospital buyer should note about the limits
The authors list the practical obstacles themselves. The gain layers need a precise and uniform concentration of quantum dots in the silicon dioxide, and the optical pump has to hold the gain and loss coefficient steady without adding noise or heat. Parity-time structures are sensitive to manufacturing tolerances, so small errors in layer thickness or refractive index can move the sensor away from its intended operating point, which the authors propose to handle by calibration. Frozen tissue at minus 20 °C also needs cryogenic sample holders and terahertz windows that preserve the sample. The paper calls these challenges significant but manageable with current nanofabrication and terahertz measurement methods.
The evidence base is narrow. The model rests on measurements of seven tissues from four patients in one laboratory, published thirteen years ago, so it cannot capture variation between patients, tumor sites or tumor stages. Because the sample must be frozen, the design applies to excised tissue in a holder; screening inside a patient's mouth lies outside its scope. The paper's data availability statement says that requests for materials or code go to the corresponding author. The manuscript was received on 14 September 2025 and accepted on 23 September 2026, and it is published under a Creative Commons non-commercial, no-derivatives license.
How Quentir Reads It
The Scientific Reports design sits at the first step of the evidence ladder for a diagnostic device. The next useful result would be a fabricated stack with pumped quantum dot gain layers, measured first on liquids of known refractive index and then on frozen resected oral tissue against histology, with diagnostic sensitivity and specificity reported for samples the model has not seen. Until such a measurement exists, terahertz parity-time sensing for oral cancer remains a physics proposal, and procurement or clinical planning has nothing to evaluate yet.
Sources
Primary source: the Scientific Reports article of 31 October 2026 by Zaky A. Zaky, Ali Hennache and Abinash Panda. Also drawn on: the 2013 Biomedical Optics Express study by Sim, Park, Ahn, Park and Son, the parity-time symmetry paper by Bender and Boettcher, the 2010 Nature Physics paper by Rüter and colleagues, and earlier Quentir coverage.